IRadimed (IRMD) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

IRadimed Revenue Highlights


Latest Revenue (Y)

$65.56M

Latest Revenue (Q)

$18.33M

Main Segment (Y)

MRI Compatible Patient Vital Signs Monitoring Systems

Main Geography (Y)

UNITED STATES

IRadimed Revenue by Period


IRadimed Revenue by Year

DateRevenueChange
2023-12-31$65.56M23.00%
2022-12-31$53.30M27.48%
2021-12-31$41.81M31.83%
2020-12-31$31.72M-17.65%
2019-12-31$38.52M26.54%
2018-12-31$30.44M31.88%
2017-12-31$23.08M-28.97%
2016-12-31$32.50M2.86%
2015-12-31$31.59M101.84%
2014-12-31$15.65M38.03%
2013-12-31$11.34M47.56%
2012-12-31$7.69M-

IRadimed generated $65.56M in revenue during NA 2023, up 23.00% compared to the previous quarter, and up 215.39% compared to the same period a year ago.

IRadimed Revenue by Quarter

DateRevenueChange
2024-09-30$18.33M2.21%
2024-06-30$17.93M1.88%
2024-03-31$17.60M0.84%
2023-12-31$17.45M5.74%
2023-09-30$16.50M2.32%
2023-06-30$16.13M4.23%
2023-03-31$15.48M4.11%
2022-12-31$14.86M10.86%
2022-09-30$13.41M5.39%
2022-06-30$12.72M3.34%
2022-03-31$12.31M3.69%
2021-12-31$11.87M8.85%
2021-09-30$10.91M11.18%
2021-06-30$9.81M6.36%
2021-03-31$9.22M7.93%
2020-12-31$8.55M11.00%
2020-09-30$7.70M13.31%
2020-06-30$6.79M-21.70%
2020-03-31$8.68M-20.32%
2019-12-31$10.89M9.31%
2019-09-30$9.96M8.00%
2019-06-30$9.23M9.34%
2019-03-31$8.44M1.18%
2018-12-31$8.34M9.52%
2018-09-30$7.61M3.22%
2018-06-30$7.38M3.78%
2018-03-31$7.11M6.01%
2017-12-31$6.70M17.84%
2017-09-30$5.69M2.99%
2017-06-30$5.52M7.01%
2017-03-31$5.16M-13.82%
2016-12-31$5.99M-21.93%
2016-09-30$7.67M-22.25%
2016-06-30$9.87M10.09%
2016-03-31$8.96M1.87%
2015-12-31$8.80M7.39%
2015-09-30$8.19M7.68%
2015-06-30$7.61M8.83%
2015-03-31$6.99M95.11%
2014-12-31$3.58M-5.99%
2014-09-30$3.81M-18.90%
2014-06-30$4.70M32.14%
2014-03-31$3.56M2.90%
2013-12-31$3.46M39.41%
2013-09-30$2.48M-10.64%
2013-06-30$2.78M5.58%
2013-03-31$2.63M-

IRadimed generated $18.33M in revenue during Q3 2024, up 2.21% compared to the previous quarter, and up 113.61% compared to the same period a year ago.

IRadimed Revenue Breakdown


IRadimed Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
MRI Compatible Patient Vital Signs Monitoring Systems$25.41M$21.72M---
MRI compatible patient vital signs monitoring systems--$13.78M--
MRI compatible IV infusion pump system--$13.29M--
M R I Compatible I V Infusion Pumps---$9.36M$18.05M
Mri Compatible Patient Vital Signs Monitoring Systems---$9.76M$9.71M

IRadimed's latest annual revenue breakdown by segment (product or service), as of Dec 23: MRI Compatible Patient Vital Signs Monitoring Systems (100.00%).

Quarterly Revenue by Product

Product/ServiceSep 24Jun 24Mar 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
MRI Compatible Patient Vital Signs Monitoring Systems$5.93M$5.45M$6.46M$14.59M$6.13M$4.70M$6.09M$5.52M------------
MRI compatible IV infusion pump system--------$3.85M$3.28M$3.96M---------
MRI compatible patient vital signs monitoring systems--------$4.92M$5.19M$4.02M---------
M R I Compatible I V Infusion Pumps-----------$3.37M$2.46M$3.50M$2.67M$2.15M$1.88M$2.66M$4.54M$4.77M
M R I Compatible Patient Vital Signs Monitoring Systems-----------$3.78M$3.38M-------
Mri Compatible Patient Vital Signs Monitoring Systems-------------$2.60M$2.93M$2.28M$1.93M$2.89M$3.49M$2.56M

IRadimed's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: MRI Compatible Patient Vital Signs Monitoring Systems (100.00%).

IRadimed Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21Dec 20Dec 19
UNITED STATES$52.53M$43.90M---
International$13.04M----
United States--$33.46M--
U---$24.54M$30.93M

IRadimed's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (80.12%), and International (19.88%).

Quarterly Revenue by Country

CountrySep 24Jun 24Mar 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
UNITED STATES$15.21M$15.49M$13.41M$27.60M$12.95M$11.98M$12.29M-------------
International$3.12M$2.44M$4.19M-----------------
United States-------$10.81M$10.82M$9.98M$9.47M---------
U-----------$8.68M$8.04M$7.27M$7.11M$6.47M$4.64M$6.32M$8.01M$8.28M

IRadimed's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (82.98%), and International (17.02%).

IRadimed Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
ITGRInteger$1.60B$746.27M
CNMDCONMED$1.24B$316.70M
LIVNLivaNova$1.15B$318.11M
GKOSGlaukos$314.71M$96.67M
ANIKAnika Therapeutics$166.66M$38.75M
KIDSOrthoPediatrics$148.73M$52.80M
SRDXSurmodics$132.58M$30.34M
SGHTSight Sciences$81.06M$20.16M
LUNGPulmonx$68.67M$20.39M
IRMDIRadimed$65.56M$18.33M
NPCENeuroPace$65.42M$21.06M
OSAProSomnus$27.65M$7.46M
OFIXOrthofix Medical$100.00K$198.62M

IRMD Revenue FAQ


What is IRadimed’s yearly revenue?

IRadimed's yearly revenue for 2023 was $65.56M, representing an increase of 23.00% compared to 2022. The company's yearly revenue for 2022 was $53.3M, representing an increase of 27.48% compared to 2021. IRMD's yearly revenue for 2021 was $41.81M, representing an increase of 31.83% compared to 2020.

What is IRadimed’s quarterly revenue?

IRadimed's quarterly revenue for Q3 2024 was $18.33M, a 2.21% increase from the previous quarter (Q2 2024), and a 11.04% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $17.93M, a 1.88% increase from the previous quarter (Q1 2024), and a 11.15% increase year-over-year (Q2 2023). IRMD's quarterly revenue for Q1 2024 was $17.6M, a 0.84% increase from the previous quarter (Q4 2023), and a 13.72% increase year-over-year (Q1 2023).

What is IRadimed’s revenue growth rate?

IRadimed's revenue growth rate for the last 3 years (2021-2023) was 56.79%, and for the last 5 years (2019-2023) was 70.22%.

What are IRadimed’s revenue streams?

IRadimed's revenue streams in c 23 are MRI Compatible Patient Vital Signs Monitoring Systems

What is IRadimed’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of IRadimed was MRI Compatible Patient Vital Signs Monitoring Systems. This segment made a revenue of $25.41M, representing 100.00% of the company's total revenue.